Published in Medical Imaging Business Week, July 27th, 2006
Study 1: A study from Australia has reported that multi-tracer small animal PET imaging reveals tumor response to pan-Erb-B inhibitor CI-1033.
"This study was designed as 'proof of concept' for a drug development model utilizing multi-tracer serial small animal PET imaging to characterize tumor responses to molecularly targeted therapy," wrote D.S. Dorow and colleagues, Peter MacCallum Cancer Center.
"Mice bearing subcutaneous A431 human squamous carcinoma xenografts (n=6-8) were treated with the pan-Erb-B inhibitor CI-1033 or vehicle and imaged...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.